New medicine supply notices

admin82291
Dec 15, 2025
3 min read

Acetylcysteine (DBL Acetylcysteine) Inj 200 mg per ml, 10 ml ampoule (Pharmacode 2260794) Pfizer's DBL Acetylcysteine will not be available from late December 2025 to March 2026. An alternative has been listed.

Amoxicillin (Ibiamox) Inj 250 mg vial (Pharmacode: 2272628) Douglas, the supplier, expects to go out of stock of the following product by mid-December because of higher-than-normal demand and shipping delays. Resupply is expected by the end of December.

Emtricitabine with tenofovir disoproxil (Pharmacode: 2638088) Due to a delay at the manufacturing plant, there is a supply issue affecting this product. We are working on an alternative.

Heparinised saline inj 10 iu per ml, 5 ml (Pfizer) There is a supply issue affecting this presentation of heparinised saline (Pharmacode: 2717840). The supplier is reserving the registered product for community use. At this stage, we do not expect people to be affected by this outage.

Levetiracetam oral liquid: Potential supply issue (Pharmacode: 2472406) The supplier has low stock of levetiracetam oral liquid. We do not expect patients to be affected but supplies are being limited.

Methenamine (hexamine) hippurate (Hiprex) tablets (Funding issue) Due to a packaging change, there may be a funding issue with Hiprex tablets (Pharmacode: 2671077). A product with a new Pharmacode has been supplied by the Radiant Health since the end of November 2025. The new Pharmacode will be listed 1 January 2026.

Notices

CGMs Allocation reset: We've been getting questions about when CGM allocations reset. Each person's allocation resets on the anniversary of their Special Authority.

Paxlovid: To support the change to supplier-owned stock, Pfizer will credit wholesalers and pharmacies for any stock from batch LY8038 that expires before it can be used.

Updated medicine supply notices

Estradot patches: reports of quality and efficacy concerns We've added further advice about the Estradot quality issues that Medsafe is investigating. Medsafe updated its medicine alert page on 3 December 2025. A free brand change flyer is available to order to support

Methylphenidate

Concerta: All strengths available
Ritalin: All strengths available
Rubifen: All strengths available, except 20 mg immediate release
Sandoz XR: Funded from 1 December, available by mid-December
Teva: All strengths available, except 27 mg.

Sodium Fusidate [fusidic acid] (Fucithalmic) Eye drops 1% (Pharmacode: 716634) The original Fucithalmic brand of eyedrops has been registered with Medsafe (Pharmacode: 716634). Delivery of this NZ-registered product is expected in February 2026. In the meantime, a section 29 alternative is available.

Testosterone (Depo-Testosterone) injections (Pharmacode: 741264) The next shipment of depo-testosterone has arrived. It will take another 1 to 2 weeks to reach pharmacies.

Resolved issues

None

Note: Supply issues are marked as resolved one week after when the supplier has product available. It can take another 1 to 2 weeks for stock to reach pharmacies around the motu.